Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors ; volume:29 ; number:1 ; day:15 ; month:7 ; year:2010 ; pages:1-8 ; date:12.2010
Journal of experimental & clinical cancer research ; 29, Heft 1 (15.7.2010), 1-8, 12.2010
- Urheber
-
Caenepeel, Sean
Renshaw-Gegg, Lisa
Baher, Angelo
Bush, Tammy L.
Baron, Will
Juan, Todd
Manoukian, Raffi
Tasker, Andrew S.
Polverino, Anthony
Hughes, Paul E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-9966-29-96
- URN
-
urn:nbn:de:101:1-2021082220492530566339
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Caenepeel, Sean
- Renshaw-Gegg, Lisa
- Baher, Angelo
- Bush, Tammy L.
- Baron, Will
- Juan, Todd
- Manoukian, Raffi
- Tasker, Andrew S.
- Polverino, Anthony
- Hughes, Paul E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
Association between CT imaging features and KIT mutations in small intestinal gastrointestinal stromal tumors
Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis